Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Muscle Nerve ; 53(2): 260-8, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26012778

RESUMEN

INTRODUCTION: Reports of muscle testing are frequently limited to maximal force alone. The experiments reported here show that force generation and relaxation rates can be obtained from the same experiments and provide a more complete functional characterization. METHODS: Partial in situ testing was performed on the tibialis anterior of young wild-type (WT) mice, young mdx mice, and old mdx mice. Force, force generation rate, and relaxation rates were measured during a fatigue test, 2 frequency-force tests, and a passive tension test. RESULTS: We measured increased force but decreased force generation rate in WT compared with mdx muscles, and increased force but decreased relaxation rate of old compared with young mdx muscles. Young mdx muscles were the most sensitive to increases in passive tension. CONCLUSIONS: These measurements offer an improved understanding of muscle capability and are readily acquired by further analysis of the same tests used to obtain force measurements.


Asunto(s)
Contracción Muscular/fisiología , Músculo Esquelético/fisiopatología , Distrofia Muscular Animal/patología , Distrofia Muscular Animal/fisiopatología , Factores de Edad , Animales , Fenómenos Biofísicos/genética , Estimulación Eléctrica , Fatiga/etiología , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos mdx , Contracción Muscular/genética , Músculo Esquelético/patología , Distrofia Muscular Animal/genética
2.
J Neurosci ; 35(4): 1606-16, 2015 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-25632136

RESUMEN

The atrophy of skeletal muscles in patients with Krabbe disease is a major debilitating manifestation that worsens their quality of life and limits the clinical efficacy of current therapies. The pathogenic mechanism triggering muscle wasting is unknown. This study examined structural, functional, and metabolic changes conducive to muscle degeneration in Krabbe disease using the murine (twitcher mouse) and canine [globoid cell leukodystrophy (GLD) dog] models. Muscle degeneration, denervation, neuromuscular [neuromuscular junction (NMJ)] abnormalities, and axonal death were investigated using the reporter transgenic twitcher-Thy1.1-yellow fluorescent protein mouse. We found that mutant muscles had significant numbers of smaller-sized muscle fibers, without signs of regeneration. Muscle growth was slow and weak in twitcher mice, with decreased maximum force. The NMJ had significant levels of activated caspase-3 but limited denervation. Mutant NMJ showed reduced surface areas and lower volumes of presynaptic terminals, with depressed nerve control, increased miniature endplate potential (MEPP) amplitude, decreased MEPP frequency, and increased rise and decay rate constants. Twitcher and GLD dog muscles had significant capacity to store psychosine, the neurotoxin that accumulates in Krabbe disease. Mechanistically, muscle defects involved the inactivation of the Akt pathway and activation of the proteasome pathway. Our work indicates that muscular dysfunction in Krabbe disease is compounded by a pathogenic mechanism involving at least the failure of NMJ function, activation of proteosome degradation, and a reduction of the Akt pathway. Akt, which is key for muscle function, may constitute a novel target to complement in therapies for Krabbe disease.


Asunto(s)
Leucodistrofia de Células Globoides/complicaciones , Leucodistrofia de Células Globoides/patología , Enfermedades Neuromusculares/etiología , Enfermedades Neuromusculares/metabolismo , Animales , Animales Recién Nacidos , Axones/metabolismo , Axones/patología , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Células Cultivadas , Modelos Animales de Enfermedad , Perros , Galactosilceramidasa/genética , Regulación de la Expresión Génica/genética , Leucodistrofia de Células Globoides/genética , Proteínas Luminiscentes/genética , Proteínas Luminiscentes/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Células Musculares/efectos de los fármacos , Células Musculares/metabolismo , Contracción Muscular/genética , Músculo Esquelético/crecimiento & desarrollo , Enfermedades Neuromusculares/patología , Psicosina/metabolismo , Receptores Nicotínicos/genética , Receptores Nicotínicos/metabolismo , Potenciales Sinápticos/efectos de los fármacos , Potenciales Sinápticos/genética
3.
J Signal Transduct ; 2012: 460842, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23251796

RESUMEN

Satellite cells can maintain or repair muscle because they possess stem cell properties, making them a valuable option for cell therapy. However, cell transplants into skeletal muscle of patients with muscular dystrophy are limited by donor cell attachment, migration, and survival in the host tissue. Cells used for therapy are selected based on specific markers present in the plasma membrane. Although many markers have been identified, there is a need to find a marker that is expressed at different states in satellite cells, activated, quiescent, or differentiated cell. Furthermore, the marker has to be present in human tissue. Recently we reported that the plasma membrane α2δ1 protein is involved in cell attachment and migration in myoblasts. The α2δ1 subunit forms a part of the L-type voltage-dependent calcium channel in adult skeletal muscle. We found that the α2δ1 subunit is expressed in the majority of newly isolated satellite cells and that it appears earlier than the α1 subunits and at higher levels than the ß or γ subunits. We also found that those cells that expressed α2δ1 would differentiate into muscle cells. This evidence indicates that the α2δ1 may be used as a marker of satellite cells that will differentiate into muscle.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...